AcelRx

AcelRx Pharmaceuticals completes divestment of DSUVIA to Alora Pharmaceuticals
Pharmaceutical Business Review
Thu, 04/6/23 - 11:31 am
AcelRx
Dsuvia
Alora Pharmaceuticals
AcelRx to Buy Lowell Therapeutics; Kala Expands Pipeline with Combangio Acquisition
BioSpace
Tue, 11/16/21 - 10:37 pm
AcelRx
Kala Pharmaceuticals
M&A
Lowell Therapeutics
Combangio
OPDP warns AcelRx over Dsuvia promotional materials
RAPS.org
Tue, 02/16/21 - 11:34 pm
FDA
OPDP
Dsuvia
AcelRx
warning letter
opioids
As it happened: A bidding war for an antibiotic maker in a market that has ravaged its peers
Endpoints
Fri, 06/5/20 - 11:01 am
antibiotics
M&A
Tetraphase
AcelRx
Melinta Therapeutics
La Jolla Pharmaceutical
A Covid-19 threat to business acquisitions
EP Vantage
Thu, 04/2/20 - 11:57 am
COVID-19
M&A
AbbVie
Allergan
Arya Sciences
Immatics
AcelRx
Tetraphase
Gilead Sciences
Forty Seven
Thermo Fisher
Stryker
Wright Medical
Another antibiotic maker bites the dust, as Tetraphase is swallowed for cheap
Endpoints
Mon, 03/16/20 - 11:02 am
antibiotics
Tetraphase
M&A
AcelRx
Sarepta, AcelRx Look to Infuse Some Cash into Their Pipelines
BioSpace
Sat, 11/10/18 - 12:00 pm
Sarepta Therapeutics
AcelRx
stock offering
FDA to develop new framework for opioid analgesics following AcelRx approval
Drug Delivery Business News
Mon, 11/5/18 - 10:02 am
FDA
opioids
Dsuvia
AcelRx
Despite criticism and concerns, FDA approves a new opioid 10 times more powerful than fentanyl
Stat
Fri, 11/2/18 - 07:51 pm
FDA
opioids
Dsuvia
AcelRx
AcelRx shares fall as Sen. Markey calls on FDA to reject opioid painkiller
Drug Delivery Business News
Mon, 10/22/18 - 10:42 am
AcelRx
Dsuvia
FDA
opioids
3 Biotechs Awaiting FDA Approval Decisions
Motley Fool
Tue, 10/16/18 - 11:52 am
FDA
TherapeuticsMD
TX-001HR
AcelRx
Dsuvia
Loxo Oncology
larotrectinib
FDA panel votes in favor of AcelRx's pain candidate
BioCentury
Fri, 10/12/18 - 11:45 pm
Dsuvia
ARX-04
FDA
AcelRx
AcelRx tackles acute pain with sublingual drug-delivery tech
Drug Delivery Business News
Fri, 06/8/18 - 10:49 am
AcelRx
acute pain
drug delivery
sublingual treatments
FDA rejection blocks another AcelRx drug from US market
Biopharma Dive
Thu, 10/12/17 - 10:16 pm
FDA
AcelRx
Dsuvia
In a new setback, FDA kicks back AcelRx’s application for pain med — shares tank again
Endpoints
Thu, 10/12/17 - 09:23 am
FDA
AcelRx
Dsuvia
ARX-04
painkillers
Why AcelRx Pharmaceuticals Inc Jumped Higher Today
Motley Fool
Mon, 10/2/17 - 10:11 pm
AcelRx
painkillers
Dsuvia
FDA
AcelRx’s pain relief drug-device combo succeeds in late-stage trial
Drug Delivery Business News
Tue, 08/1/17 - 10:52 pm
AcelRx
Zalviso
devices
drug-device combos
5 Biotech Stocks With Major Catalysts in July
Motley Fool
Wed, 06/28/17 - 11:03 pm
biotech
AcelRx
Zalviso
Alnylam
Patisiran
Dynavax
HEPLISAV-B
GSK
Benlysta
Puma Biotechnology
neratinib
AcelRx's opioid painkiller succeeds in key study
Yahoo/Reuters
Thu, 09/15/16 - 09:28 am
AcelRx
opioids
painkillers
clinical trials
AcelRx Pharma's pain drug succeeds in late-stage study
Yahoo/Reuters
Wed, 09/9/15 - 10:40 am
AcelRx
painkillers
ARX-04

Pages